This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
L01XX Other antineoplastic agents
RX_L01XX
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
2624 |
4. Check minimum number of events
Min. number of events
3
|
2624 |
5. Include endpointsNone |
2624 |
6. Filter based on genotype QC (FinnGen only) |
2236 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF3
L01XX Other antineoplastic agents
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2236 | 1090 | 1146 |
| Unadjusted period prevalence (%) | 0.46 | 0.39 | 0.53 |
| Median age at first event (years) | 68.54 | 67.58 | 69.44 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2314
- Matched controls
- 23140
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01XX11
ATC
estramustine; systemic
163.8
309.2
153
10
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
1014.2
307.7
346
*
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
231.4
307.7
248
12
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
35.4
307.7
292
94
L01XX05
ATC
hydroxycarbamide; oral
4391.2
307.7
1741
16
TPH00
NOMESCO Finland
Phlebotomy
268.9
307.7
324
14
SPAT1074
SPAT
Venesection
124.5
307.7
225
20
D75.2
ICD-10 Finland
Essential thrombocytosis
452.4
307.7
674
21
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
725.4
307.7
945
22
D45
ICD-10 Finland
Polycythaemia vera
359.8
307.7
801
34
L03AB05
ATC
interferon alfa-2b; parenteral
111.4
307.7
194
19
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
277.5
307.7
1977
479
XW000
NOMESCO Finland
Bone marrow biopsy
23.5
307.7
824
531
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
2421.4
307.7
424
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
22.3
291.7
219
108
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
53.1
284.4
163
33
L01XX35
ATC
anagrelide; oral
+∞
280.0
263
*
B99
ICPC
Blood/lymph/spleen disease other
56.8
246.1
139
26
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
26.9
225.4
156
62
L01XX52
ATC
venetoclax; oral
1140.7
216.1
208
*
TPH00, ,
SPAT
114.3
213.3
109
10
M04AA01
ATC
allopurinol; systemic
4.1
202.5
752
2435
399
Kela drug reimbursment
Venetoclax
523.3
196.6
193
*
1518, ,
Kela drug reimbursment
487.7
183.8
181
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.7
156.3
621
2066
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
34.6
146.4
93
28
B74
ICPC
Malignant neoplasm blood other
70.4
137.8
75
11
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
346.3
132.0
132
*
212
Kela drug reimbursment
Gout
7.8
123.6
178
245
L03AA02
ATC
filgrastim; parenteral
6.3
116.7
208
359
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
591.6
115.0
113
*
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
23.6
113.5
82
36
WW500
NOMESCO Finland
Blood transfusion
5.3
111.0
239
492
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
37.7
106.5
66
18
174
Kela drug reimbursment
Ruxolitinib
542.0
105.6
104
*
L03AB04
ATC
interferon alfa-2a; parenteral
224.2
104.5
107
5
189
Kela drug reimbursment
Imatinib
39.8
101.5
62
16
374
Kela drug reimbursment
Ruxolitinib
492.8
96.1
95
*
1850A
ICD-9 Finland
Malignant neoplasm of prostate[NEOPLASMA MALIGNUM PROSTATAE]
27.8
95.7
65
24
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
13.4
92.5
88
68
L01EJ01
ATC
ruxolitinib; oral
449.3
87.7
87
*
B28
ICPC
Limited function/disability (B)
18.0
80.3
65
37
L01XE01
ATC
[U] imatinib
37.7
77.4
48
13
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
23.5
76.1
55
24
B03XA02
ATC
darbepoetin alfa; parenteral
5.7
75.8
146
270
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
7.4
74.9
111
157
A04AA01
ATC
ondansetron; systemic, rectal
3.1
72.3
336
1190
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.9
62.8
341
1312
L01XX28
ATC
[U] imatinib
+∞
60.7
58
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.2
60.6
129
261
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
12.2
55.8
56
47
L03AA04, ,
ATC
23.9
55.7
40
17
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
10.2
55.0
62
62
390
Kela drug reimbursment
Ibrutinib
72.8
50.2
57
8
1512
Kela drug reimbursment
Ibrutinib
82.0
50.1
56
7
B03XA01
ATC
erythropoietin; parenteral
8.2
50.0
67
84
L01XE18
ATC
[U] ruxolitinib
239.8
46.1
47
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
17.4
43.7
36
21
L01XE27
ATC
[U] ibrutinib
149.4
41.9
44
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
15.9
41.8
36
23
372
Kela drug reimbursment
Idelalisib
394.0
39.2
39
*
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
13.4
39.1
37
28
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
39.0
1324
9929
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
36.1
188
701
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
34.7
376
1950
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
58.1
34.3
40
7
B04
ICPC
Blood symptom/complaint
8.3
34.3
45
55
L01XX47
ATC
[U] idelalisib
342.1
34.0
34
*
B01AB05
ATC
enoxaparin; parenteral
1.7
34.0
856
5826
8461/3-C56.9
ICD-O-3
High grade serous carcinoma of ovary
11.4
33.6
35
31
R50.9
ICD-10 Finland
Fever, unspecified
2.0
33.3
417
2276
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
331.7
33.0
33
*
ZX120
NOMESCO Finland
Intravenous
2.3
32.9
286
1357
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.4
31.7
245
1104
L01BB05
ATC
fludarabine; systemic
53.7
31.3
37
7
L01XX23
ATC
mitotane; oral
+∞
31.3
30
*
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
5.0
30.8
67
138
116
Kela drug reimbursment
Prostate cancer
2.4
30.6
225
992
L01XX54
ATC
[U] niraparib
+∞
30.3
29
*
L01XX46
ATC
[U] olaparib
+∞
30.3
29
*
7512
FHL
Orchidectomy (bilateral)
35.1
29.7
38
11
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.5
29.5
194
812
B01AC14
ATC
[U] anagrelide
+∞
29.2
28
*
C90.0
ICD-10 Finland
Multiple myeloma
4.9
29.1
64
133
H02AB09
ATC
hydrocortisone; systemic
4.0
29.1
85
221
L01XX50
ATC
[U] ixazomib
295.6
28.8
29
*
1511
Kela drug reimbursment
Olaparib
81.2
28.8
32
*
B73
ICPC
Leukaemia
36.5
28.4
36
10
389
Kela drug reimbursment
Olaparib
78.6
27.8
31
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
25.7
27.5
38
15
D75.1
ICD-10 Finland
Secondary polycythaemia
7.5
25.9
37
50
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
6.0
25.6
45
76
1505
Kela drug reimbursment
Ixazomib
58.7
25.0
29
5
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
2.7
24.7
136
521
ZX112
NOMESCO Finland
Subcutaneous
3.5
24.5
84
244
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
20.3
24.3
36
18
398
Kela drug reimbursment
Ixazomib
48.9
24.3
29
6
3009
Kela drug reimbursment
Niraparib
34.9
24.3
31
9
1510
Kela drug reimbursment
Niraparib
34.9
24.3
31
9
JN4AD
NOMESCO Finland
Body CT examination
1.9
24.1
351
2001
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.9
24.0
327
1824
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.6
23.7
140
556
JN6AD
NOMESCO Finland
CT of torso and neck
3.9
23.4
70
185
B01AB10
ATC
tinzaparin; parenteral
1.9
23.1
304
1674
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
6.4
23.1
38
60
C74.0
ICD-10 Finland
Malignant neoplasm: Cortex of adrenal gland
54.6
23.1
27
5
L02BB03
ATC
bicalutamide; oral
2.9
22.8
112
404
S97
ICPC
Chronic ulcer skin
2.2
22.7
212
1030
L01AB01
ATC
busulfan; systemic
232.2
22.7
23
*
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
18.6
21.7
33
18
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
4.5
21.5
52
117
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.0
21.2
269
1461
L01EL01
ATC
ibrutinib; oral
50.5
21.1
25
5
J05AB11
ATC
valaciclovir; oral
1.8
20.8
349
2074
L01AA02
ATC
chlorambucil; oral
8.3
20.5
27
33
316
Kela drug reimbursment
Imatinib
42.1
20.5
25
6
L01EA01
ATC
imatinib; oral
25.7
20.4
28
11
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
5.5
20.3
39
72
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
2.8
20.2
100
362
L01XK01
ATC
olaparib; oral
58.0
19.9
23
*
A05AA02
ATC
ursodeoxycholic acid; oral
4.4
18.8
47
109
WW200
NOMESCO Finland
Immunization
3.2
18.7
76
246
D75.0
ICD-10 Finland
Familial erythrocytosis
30.3
18.3
24
8
J02AC03
ATC
voriconazole; systemic
16.3
18.3
29
18
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
6.1
18.1
31
51
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
17.8
162
778
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
17.8
154
725
G03HA01
ATC
cyproterone; systemic
5.1
17.6
37
74
L01XX17
ATC
[U] topotecan
95.8
17.6
19
*
8370/3-C74.0
ICD-O-3
Adrenal cortical carcinoma of cortex of adrenal gland
181.3
17.5
18
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.3
17.5
35
67
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
24.2
17.3
24
10
L02BB01
ATC
flutamide; oral
12.6
17.1
30
24
I81
ICD-10 Finland
Portal vein thrombosis
7.2
17.0
25
35
D73.5
ICD-10 Finland
Infarction of spleen
19.4
16.9
25
13
L02AE03
ATC
goserelin; implant
4.1
16.7
46
115
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
2.3
16.5
130
589
A03FA01
ATC
metoclopramide; systemic, rectal
1.6
16.5
517
3599
L57.0
ICD-10 Finland
Actinic keratosis
1.7
16.3
326
2029
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
15.8
806
6198
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
33.6
15.7
20
6
KFC10
NOMESCO Finland
Bilateral orchiectomy
6.9
15.7
24
35
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
7.2
15.7
23
32
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
13.0
15.7
27
21
D70.89
ICD-10 Finland
Neutropenic splenomegaly
3.9
15.6
46
121
B75
ICPC
Neoplasm blood benign/unspecified
85.7
15.6
17
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
3.1
15.2
65
217
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
2.8
15.2
78
289
ZX108
NOMESCO Finland
Inhalation
5.3
15.1
30
57
L01XK02
ATC
niraparib; oral
23.5
15.1
21
9
L03AA13
ATC
pegfilgrastim; parenteral
2.2
15.0
122
560
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
3.0
15.0
64
214
128
Kela drug reimbursment
Cancers of female genital organs
3.2
14.7
59
190
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
3.6
14.6
48
136
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
+∞
14.6
14
*
1XC02, ,
NOMESCO Finland
5.0
14.5
31
63
L04AX04
ATC
lenalidomide; oral
4.8
14.5
32
67
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
36.3
14.4
18
5
XW000, ,
SPAT
36.3
14.4
18
5
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
19.3
14.2
21
11
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
3.1
14.1
60
200
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.0
14.0
157
816
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.6
13.6
80
318
TGC00
NOMESCO Finland
Bronchial lavation
2.6
13.5
77
301
1532, ,
Kela drug reimbursment
140.8
13.5
14
*
3059, ,
Kela drug reimbursment
140.8
13.5
14
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.7
13.4
265
1639
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.7
13.4
275
1718
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.4
13.4
48
144
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
3.6
13.4
44
125
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
25.9
13.4
18
7
TQW99
NOMESCO Finland
Other minor procedure on skin
2.0
13.4
150
780
153
Kela drug reimbursment
Lenalidomid
4.6
13.3
31
68
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.7
13.2
41
112
JN4BD
NOMESCO Finland
Extensive body CT
1.7
13.1
269
1681
A10BA02
ATC
metformin; oral
0.7
13.0
395
5543
C03CA01
ATC
furosemide; systemic
1.4
13.0
850
6777
XQ848
NOMESCO Finland
Dermatological photography
2.4
12.8
84
351
Z3231
NOMESCO Finland
Registered nurse
1.4
12.8
608
4573
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.7
12.7
66
246
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
12.7
601
4519
C83.00
ICD-10 Finland
Lymphocytic lymphoma
9.3
12.5
25
27
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
24.4
12.5
17
7
L01EL02
ATC
acalabrutinib; oral
130.7
12.4
13
*
Z51.5
ICD-10 Finland
Palliative care
1.7
12.2
257
1616
103
Kela drug reimbursment
Diabetes, insulin-treated
0.7
12.2
371
5219
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.0
12.2
138
720
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
12.1
256
1612
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.8
12.0
179
1022
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.3
11.9
89
395
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
5.1
11.7
24
47
1507
Kela drug reimbursment
Pomalidomide
9.7
11.7
23
24
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
3.5
11.7
40
117
ZYC05
NOMESCO Finland
Non-real-time text-based remote communication
3.5
11.7
40
117
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.6
11.7
27
59
R04.0
ICD-10 Finland
Epistaxis
1.7
11.6
205
1230
393
Kela drug reimbursment
Pomalidomide
8.6
11.5
24
28
D06BB10
ATC
imiquimod; topical
2.0
11.4
132
695
L04AX06
ATC
pomalidomide; oral
8.9
11.2
23
26
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
11.2
218
1344
9823/3-C77.9
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of lymph node, NOS
25.1
11.1
15
6
SPAT1088
SPAT
Blood transfusion
4.8
11.0
24
50
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
2.8
11.0
55
202
C74.9
ICD-10 Finland
Malignant neoplasm: Adrenal gland, unspecified
43.5
10.9
13
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.7
10.8
227
1426
ZYC01
NOMESCO Finland
Remote contact by phone
1.9
10.8
132
707
9732/3-C42.1
ICD-O-3
Plasma cell myeloma of bone marrow
3.8
10.8
32
85
C56
ICD-10 Finland
Malignant neoplasm of ovary
4.6
10.7
25
55
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
10.7
493
3673
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.4
10.7
690
5448
7461
FHL
Needle biopsy in the operating room
10.1
10.5
20
20
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
110.5
10.4
11
*
L01EM01
ATC
idelalisib; oral
+∞
10.4
10
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.6
10.3
266
3894
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
9.9
75
335
N02AA05
ATC
oxycodone; systemic
1.4
9.9
483
3629
BCA30
NOMESCO Finland
Unilateral adrenalectomy
16.8
9.9
15
9
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.4
9.7
63
263
J01MA12
ATC
levofloxacin; systemic
1.4
9.6
432
3197
L01AA04, ,
ATC
100.4
9.4
10
*
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
30.1
9.4
12
*
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.2
9.4
74
337
PH_2
NOMESCO Finland
Other procedures on veins
+∞
9.4
9
*
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.4
9.4
531
4091
J01DB01
ATC
cefalexin; oral
1.4
9.2
1750
16062
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
9.2
498
3808
GD1AD
NOMESCO Finland
Thorax CT examination
1.7
9.1
162
975
B01AB04
ATC
dalteparin; parenteral
1.9
9.0
117
641
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.8
813
6732
WW409
NOMESCO Finland
Other aferesis
10.7
8.8
16
15
Z2221
NOMESCO Finland
Medical doctor
1.4
8.8
542
4229
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
50.2
8.7
10
*
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.6
8.6
181
2783
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.6
321
2290
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
4.6
8.6
20
44
D59.1
ICD-10 Finland
Other autoimmune haemolytic anaemias
4.6
8.6
20
44
L01AA01
ATC
cyclophosphamide; systemic
4.8
8.6
19
40
306
Kela drug reimbursment
Erythropoietin and darbepoetin
6.4
8.5
21
33
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.7
8.5
337
4550
127
Kela drug reimbursment
Transplant complication
3.0
8.3
35
117
C57.9
ICD-10 Finland
Malignant neoplasm: Female genital organ, unspecified
9.5
8.3
16
17
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
3.8
8.2
24
63
L71.9
ICD-10 Finland
Rosacea, unspecified
2.3
8.2
60
265
ZZR00
NOMESCO Finland
Flap of skin
2.2
8.2
64
291
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.1
8.1
70
332
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
33.5
8.1
10
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.5
8.0
295
2098
9945/3-C42.1
ICD-O-3
Chronic myelomonocytic leukemia, NOS, of bone marrow
22.1
8.0
11
5
T90
ICPC
Diabetes non-insulin dependent
0.7
7.8
359
4738
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.3
7.7
630
5108
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.9
7.7
91
483
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
45.1
7.7
9
*
150
Kela drug reimbursment
Dasatinib
45.1
7.7
9
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
45.1
7.7
9
*
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
4.3
7.7
19
44
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
7.6
857
7253
ZY010
NOMESCO Finland
Hospital outpatient
2.0
7.5
81
417
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
7.1
7.5
17
24
R51.80
ICD-10 Finland
Headache
1.5
7.4
271
1926
S91.0
ICD-10 Finland
Open wound of ankle
3.1
7.3
30
99
D57.1
ICD-10 Finland
Sickle-cell anaemia without crisis
+∞
7.3
7
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.7
7.3
372
4834
JAL30
NOMESCO Finland
Omentectomy
2.9
7.3
32
110
A41.9
ICD-10 Finland
Sepsis, unspecified
1.9
7.3
89
479
UJF30
NOMESCO Finland
Ileoscopy through colon
1.5
7.3
223
1530
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.2
280
2012
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
30.1
7.1
9
*
C93.1
ICD-10 Finland
Chronic myelomonocytic leukaemia
30.1
7.1
9
*
L02AA02
ATC
polyestradiol phosphate; parenteral
20.1
7.1
10
5
H02AA02
ATC
fludrocortisone; oral
3.3
7.1
26
80
K93
ICPC
Pulmonary embolism
3.0
7.1
30
101
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
1.9
7.1
83
441
A10BB12
ATC
glimepiride; oral
0.5
7.0
60
1184
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
3.4
7.0
24
71
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.5
6.9
215
1479
A02BC02
ATC
pantoprazole; systemic
1.3
6.9
1514
13831
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.5
6.9
247
1749
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
6.7
6.8
16
24
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
1.8
6.8
89
490
L03AA14
ATC
lipegfilgrastim; parenteral
2.5
6.8
42
173
L01XE06
ATC
[U] dasatinib
40.2
6.8
8
*
AA1AD
NOMESCO Finland
CT of head and brain
1.3
6.7
703
5875
R71
ICD-10 Finland
Abnormality of red blood cells
7.2
6.7
15
21
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
2.7
6.7
34
127
TQW80
NOMESCO Finland
Local dermatologic skincare
2.0
6.7
64
317
N02AX02
ATC
tramadol; systemic, rectal
1.3
6.6
933
8080
D73.1
ICD-10 Finland
Hypersplenism
12.3
6.6
11
9
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
3.5
6.6
22
64
6BA02, ,
NOMESCO Finland
8.7
6.5
13
15
1XC07, ,
NOMESCO Finland
6.9
6.5
15
22
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
70.0
6.4
7
*
J05AX18
ATC
letermovir; oral
70.0
6.4
7
*
V04CD01
ATC
metyrapone; oral
70.0
6.4
7
*
A10BK03
ATC
empagliflozin; oral
0.6
6.4
108
1752
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
6.4
276
2021
C48.89
ICD-10 Finland
Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor
14.3
6.4
10
7
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
3.0
6.4
27
91
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
3.7
6.4
19
51
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
1.8
6.3
84
465
D69.5
ICD-10 Finland
Secondary thrombocytopenia
6.6
6.3
15
23
WW300
NOMESCO Finland
Transfer of autologic stem cells
6.0
6.3
16
27
D68.8
ICD-10 Finland
Other specified coagulation defects
3.2
6.3
24
76
8370/3-C74.9
ICD-O-3
Adrenal cortical carcinoma of adrenal gland, NOS
+∞
6.3
6
*
L29.8
ICD-10 Finland
Other pruritus
2.7
6.3
32
120
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
6.2
791
6753
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
6.2
161
1065
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
1.7
6.2
109
655
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
6.3
6.2
15
24
H02AB02
ATC
dexamethasone; systemic
1.4
6.1
250
1813
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.3
6.1
439
3483
K99
ICPC
Cardiovascular disease other
1.9
6.1
69
363
1AA09, ,
NOMESCO Finland
12.5
6.1
10
8
WX892
NOMESCO Finland
Monitored bed care
1.5
6.1
169
1137
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.4
6.0
257
1879
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
696
390
25.09
307.65
1.7
1.5
—
—
—
0
0
1250
3016
7.84
307.65
5.7
2.4
1.92
1.81
%
2.39
1155
2684
700
395
24.97
307.65
1.3
1.3
32.78
43.07
u/l
0.49
578
338
678
209
45.47
307.65
1.1
1.1
—
—
—
0
0
1779
2898
23.23
307.65
15.4
3.7
280.49
246.58
u/l
10.07
1740
2734
1532
5758
5.91
307.65
7.5
2.9
342.41
353.70
umol/l
4.13
1454
4951
1120
2366
8.24
307.65
5.7
2.5
75.36
68.69
e9/l
5.52
809
1755
1917
9802
6.57
302.68
24.0
6.2
2.33
2.84
%
27.07
1886
9137
1898
9746
6.27
294.40
22.8
6.2
59.45
58.17
%
3.46
1869
9260
1918
9955
6.41
293.02
24.0
6.3
26.49
26.38
%
0.12
1890
9386
1963
10590
6.63
280.23
21.9
6.0
0.64
0.61
e9/l
0.93
1826
8903
1964
10618
6.62
279.11
21.8
6.0
0.07
0.04
e9/l
45.76
1829
8933
1969
10783
6.54
272.03
22.3
6.1
2.55
1.87
e9/l
3.65
1859
9314
1977
10920
6.56
268.63
24.4
6.1
0.20
0.20
e9/l
0.02
1853
9359
989
3531
4.15
237.42
2.9
2.7
22.86
21.89
%
1.23
955
3287
1020
3789
4.03
230.04
2.8
2.7
2.33
2.26
g/l
3.49
984
3494
2004
11944
6.06
227.04
34.1
9.3
5.02
4.24
e9/l
9.20
1900
10266
1043
4035
3.89
219.69
2.9
2.7
13.14
12.26
umol/l
3.27
1012
3764
365
606
6.96
216.25
3.2
2.3
3.38
3.62
g/l
2.32
350
576
356
621
6.59
200.48
2.1
1.5
—
—
—
0
0
511
1253
4.95
197.78
2.4
1.7
1.08
1.55
g/l
24.99
456
1085
284
404
7.87
193.20
10.8
3.5
1.25
1.51
%
0.62
256
356
259
417
6.87
156.56
6.5
5.2
317.59
736.58
iu/ml
0.68
37
62
1824
11675
3.66
148.88
15.1
6.8
12.09
12.07
umol/l
0.01
1796
11148
193
264
7.88
134.90
11.4
3.5
58.28
58.18
%
0.02
162
225
206
335
6.65
122.73
2.7
2.4
231.36
1001.12
u/ml
0.74
14
26
1476
9041
2.75
116.32
4.4
3.1
170.05
149.52
ug/l
1.42
1399
8276
268
589
5.02
115.50
3.1
2.1
94.68
89.75
%
2.82
239
575
125
134
9.80
105.90
2.2
1.4
—
—
—
0
0
125
134
9.80
105.90
2.2
1.4
—
—
—
0
0
58
10
59.47
103.47
4.6
7.5
—
—
—
0
0
456
1591
3.32
102.74
5.2
2.9
9.34
10.80
g/l
5.44
435
1456
66
21
32.32
101.94
1.1
1.0
—
—
—
0
0
711
3276
2.69
96.08
7.9
5.7
1.09
1.03
mmol/l
6.91
686
3026
1420
9094
2.45
92.95
33.3
12.4
0.06
0.00
e9/l
3.65
1269
7344
140
203
7.28
92.52
2.1
1.8
3.48
4.45
mg/l
2.59
140
197
1674
11743
2.54
86.67
13.4
7.6
1.21
1.21
mmol/l
0.34
1473
10090
221
549
4.34
81.08
3.6
2.3
184.95
203.63
%
2.11
215
519
1045
6169
2.27
78.16
2.7
2.4
4.89
2.89
mg/l
21.61
929
5293
98
115
8.85
77.32
2.7
2.7
30.32
40.56
%
2.43
34
69
1142
7062
2.22
75.36
2.1
1.8
19.97
20.24
nmol/l
0.24
1043
5864
1515
10642
2.23
70.67
11.5
6.8
1.22
1.21
mmol/l
3.70
1430
9790
501
2253
2.56
68.28
4.2
2.7
65.46
66.29
g/l
1.42
466
2073
2000
16179
2.74
62.17
24.0
8.6
84.05
81.28
u/l
2.05
1970
15317
681
3636
2.24
62.14
3.0
2.0
31.22
29.82
s
5.48
643
3537
728
3998
2.20
61.90
4.6
3.2
0.82
0.81
mmol/l
0.86
702
3759
210
625
3.60
59.38
2.9
1.5
—
—
—
0
0
58
47
12.63
59.10
1.4
1.4
—
—
—
0
0
63
7
92.54
57.14
1.4
1.1
—
—
—
0
0
904
5534
2.04
56.63
6.5
4.3
83.24
85.95
%
2.58
863
5429
97
160
6.28
56.55
2.4
2.4
14.17
40.51
iu/ml
—
8
27
319
1271
2.75
54.63
2.2
1.9
1.14
1.48
g/l
1.90
282
1153
197
608
3.45
52.54
2.6
1.5
—
—
—
0
0
1413
10341
1.94
50.41
8.0
5.1
35.30
34.88
g/l
1.96
1358
9686
1419
10403
1.94
50.32
2.7
2.3
90.18
94.74
pmol/l
3.63
945
5405
74
104
7.32
50.11
2.9
2.0
1.17
0.71
e9/l
0.30
69
98
199
644
3.29
49.14
3.5
2.8
1.38
1.71
mg/l
7.43
189
573
493
2509
2.23
49.12
5.6
2.7
7.49
8.94
umol/l
1.03
455
2245
71
100
7.29
47.98
3.4
1.9
211.07
230.45
e6/l
0.23
60
89
248
956
2.79
44.90
6.5
3.6
42.00
53.27
mg/l
0.92
229
828
736
4480
1.94
44.51
2.5
1.7
1.34
1.52
mg/l
0.75
588
3557
247
956
2.77
44.36
6.5
3.6
42.98
74.60
mg/l
1.04
229
829
261
1048
2.68
43.61
3.4
2.5
2.91
2.95
g/l
0.30
242
953
273
1123
2.62
43.45
3.4
2.5
3.33
3.77
g/l
4.53
254
1028
273
1124
2.62
43.37
3.4
2.5
4.11
4.20
g/l
0.86
255
1030
273
1124
2.62
43.37
3.4
2.5
6.69
7.45
g/l
13.35
255
1028
74
123
6.18
42.78
1.8
1.9
—
—
—
0
0
119
312
3.97
40.24
1.3
1.3
146.91
158.81
au/ml
0.41
35
93
142
424
3.50
39.72
3.2
1.6
—
—
—
0
0
70
119
6.03
39.56
1.9
1.9
14.40
16.43
%
0.59
65
112
690
4249
1.89
39.40
3.1
1.9
—
—
—
0
0
158
514
3.23
38.55
1.8
1.4
—
—
—
0
0
55
76
7.39
37.79
2.0
2.4
191.64
34201.57
u/ml
0.53
11
14
1626
13020
1.84
37.74
7.2
5.3
6.54
6.86
mmol/l
11.25
1595
12478
62
98
6.47
37.65
3.1
1.8
1328.81
561.36
e6/l
0.60
47
80
237
976
2.59
37.45
3.9
2.5
1.44
1.12
g/l
0.44
211
840
211
820
2.73
37.43
3.2
2.4
0.01
0.02
g/l
0.17
191
741
113
301
3.90
37.37
1.2
1.2
341.93
274.49
u/ml
0.81
57
167
66
112
6.04
37.37
5.7
3.5
1.15
1.13
%
0.03
66
112
217
858
2.69
37.21
6.3
3.4
17.52
3.41
ratio
0.54
146
516
142
444
3.34
36.93
1.7
1.4
—
—
—
0
0
235
974
2.57
36.62
3.4
2.5
10.18
10.43
g/l
0.30
215
868
41
8
52.12
34.50
8.5
12.6
—
—
—
0
0
83
186
4.59
34.45
1.4
1.2
—
—
—
0
0
199
791
2.66
33.70
3.1
2.4
0.00
0.00
g/l
-0.00
176
700
188
739
2.68
32.53
3.2
2.4
0.00
0.00
g/l
-0.00
176
699
533
3231
1.84
30.84
2.5
1.9
—
—
—
0
0
79
187
4.34
30.62
1.7
1.5
—
—
—
0
0
139
480
3.02
30.58
1.1
1.2
—
—
—
0
0
87
230
3.89
29.08
4.2
1.4
—
—
—
0
0
89
247
3.71
27.76
4.1
1.4
—
—
—
0
0
330
1763
2.02
27.66
2.1
1.6
—
—
—
0
0
126
441
2.96
27.06
2.0
1.4
—
—
—
0
0
44
72
6.21
25.84
1.4
1.4
—
—
—
0
0
98
307
3.29
25.40
1.6
1.6
—
—
—
0
0
484
3016
1.76
24.91
2.5
1.9
—
—
—
0
0
641
4324
1.67
24.64
1.8
1.8
1064.55
1168.17
nmol/l
2.21
481
3264
81
230
3.61
24.45
3.3
2.8
—
—
—
0
0
107
363
3.04
24.28
2.0
1.4
—
—
—
0
0
45
82
5.58
23.69
5.3
1.4
—
—
—
0
0
45
82
5.58
23.69
5.3
1.4
—
—
—
0
0
1366
11087
1.57
23.61
20.4
18.0
1.33
1.32
inr
0.48
1168
9291
45
84
5.44
23.09
5.4
1.4
—
—
—
0
0
1757
15178
1.65
22.92
6.2
4.6
13.00
13.94
mm/h
1.51
1666
14099
32
44
7.36
22.06
1.4
1.3
—
—
—
0
0
51
114
4.55
21.29
4.9
1.4
—
—
—
0
0
51
114
4.55
21.29
4.9
1.4
—
—
—
0
0
51
114
4.55
21.29
4.9
1.4
—
—
—
0
0
51
114
4.55
21.29
4.9
1.4
—
—
—
0
0
546
3687
1.63
20.30
2.2
1.5
2.20
2.68
g/l
4.57
368
2126
51
119
4.36
20.19
1.2
1.1
—
—
—
0
0
289
1641
1.87
19.90
2.1
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
181
880
2.15
19.32
3.5
2.7
0.34
0.35
iu/ml
0.20
114
489
212
1105
2.01
18.78
2.4
1.9
1.40
2.27
ug/l
0.77
193
979
1217
9949
1.47
18.06
5.9
2.9
—
—
estimate
—
0
0
32
55
5.89
17.91
1.2
1.0
—
—
—
0
0
1007
7942
1.47
17.91
3.5
3.3
1980.46
1522.06
ng/l
1.30
906
6943
65
200
3.32
17.40
4.3
1.3
—
—
—
0
0
65
200
3.32
17.40
4.3
1.3
—
—
—
0
0
65
200
3.32
17.40
4.3
1.3
—
—
—
0
0
318
1933
1.75
17.35
4.7
4.0
1.22
1.23
mmol/l
2.32
277
1673
321
1972
1.73
16.84
3.2
2.3
419.00
380.29
nmol/l
2.22
302
1814
73
248
3.01
16.59
1.2
1.2
2.56
4.30
u/ml
0.60
36
83
28
46
6.15
16.39
1.7
1.3
—
—
—
0
0
69
230
3.06
16.21
1.1
1.1
—
—
—
0
0
362
2321
1.66
16.16
5.9
6.9
10.47
10.70
mmol/l
0.24
343
2219
35
72
4.92
16.16
1.1
1.2
—
—
—
0
0
84
315
2.73
15.94
1.8
1.5
—
—
—
0
0
133
632
2.17
15.04
2.8
3.6
1.16
1.95
index
1.17
74
323
40
98
4.14
14.92
2.1
2.6
2054.95
1294.55
u/ml
0.92
40
98
158
806
2.03
14.83
1.6
1.3
—
—
—
0
0
66
227
2.96
14.71
1.1
1.1
111.74
115.43
%
0.50
61
205
723
5529
1.45
14.23
6.2
2.5
—
—
—
0
0
857
6763
1.42
14.20
5.6
3.2
30.38
37.98
u/l
1.99
816
6355
26
47
5.58
13.84
2.2
2.0
31.71
28.70
%
0.27
21
40
53
168
3.21
13.58
1.1
1.0
—
—
—
0
0
34
81
4.25
13.17
1.1
1.2
1.11
1.07
ratio
1.21
27
68
823
6519
1.41
13.07
3.7
3.5
0.53
0.47
e6/l
0.21
630
4891
64
238
2.74
12.41
1.2
1.2
3.93
4.51
u/ml
0.10
30
110
1011
8348
1.37
12.29
4.5
4.2
120.22
112.20
e6/l
0.11
748
6073
1293
11127
1.37
11.99
4.4
4.3
0.00
0.14
estimate
0.57
346
2279
25
50
5.04
11.94
1.3
1.2
67.86
81.28
%
1.07
14
29
46
145
3.22
11.93
1.3
1.2
—
—
—
0
0
921
7551
1.36
11.45
3.8
3.6
53.72
80.05
e6/l
0.58
726
5866
1277
11041
1.35
11.09
4.4
4.3
3.43
3.28
estimate
0.01
358
2453
115
582
2.03
11.08
1.2
1.6
1.11
1.19
g/l
2.10
109
559
112
566
2.03
10.84
1.3
1.6
0.23
0.24
g/l
0.43
105
543
24
51
4.74
10.71
1.3
1.6
75.00
78.84
%
0.16
14
31
1259
10908
1.34
10.54
4.4
4.3
0.00
0.00
estimate
0.50
342
2380
160
921
1.79
10.44
3.5
2.6
—
—
—
0
0
597
4634
1.39
10.17
4.4
4.3
529.90
574.03
ng/l
0.04
510
3954
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
21
26
8.14
9.82
1.3
1.3
68.10
69.86
%
—
10
7
21
26
8.14
9.82
1.3
1.3
69.70
75.75
%
—
10
8
2033
19120
1.52
9.73
40.4
18.9
21.98
26.74
mg/l
10.62
1844
16132
63
264
2.43
9.65
1.3
1.3
247.60
312.31
pmol/l
0.92
48
231
160
944
1.75
9.61
3.9
1.9
—
—
—
0
0
34
103
3.34
9.45
2.4
1.3
—
—
—
0
0
34
103
3.34
9.45
2.4
1.3
—
—
—
0
0
150
874
1.77
9.41
2.5
1.8
—
—
—
0
0
1128
9718
1.31
9.36
2.9
2.4
—
—
—
0
0
948
8046
1.30
8.50
4.1
3.6
2.33
2.36
mmol/l
5.55
875
7231
50
201
2.52
8.41
1.8
1.6
—
—
—
0
0
71
334
2.16
8.36
6.2
6.7
12.22
12.81
mg/l
0.51
65
317
78
382
2.08
8.28
1.4
1.3
—
—
—
0
0
658
5330
1.33
8.22
2.9
2.8
4.90
5.22
e6/l
0.30
621
4875
42
158
2.69
8.07
2.1
1.3
—
—
—
0
0
486
3787
1.36
7.82
3.5
3.3
1.51
2.25
e6/l
2.26
227
1926
14
13
10.83
7.79
1.3
1.5
—
—
—
0
0
108
607
1.82
7.69
1.5
1.6
0.78
11.91
iu/ml
0.53
13
114
148
910
1.67
7.68
2.8
2.1
286.83
779.66
ug/l
1.41
140
867
57
254
2.28
7.67
1.3
1.2
0.18
0.19
nmol/l
0.21
37
208
257
1798
1.48
7.61
4.2
3.0
57.63
61.39
ml/min/173m2
1.27
166
790
1535
13973
1.29
7.60
5.6
5.2
4478.85
1567.07
e6/l
0.29
13
227
101
561
1.84
7.48
1.5
1.5
—
—
—
0
0
30
98
3.09
7.44
1.4
5.9
—
67.65
—
0
20
99
549
1.84
7.37
2.0
2.0
17.68
12.44
mg/l
1.50
88
501
824
6972
1.28
7.25
3.2
2.7
53.33
73.42
u/l
1.08
770
6435
40
157
2.57
7.11
2.2
1.3
—
—
—
0
0
50
221
2.29
6.89
1.3
1.2
45.64
57.65
u/l
1.45
44
198
37
142
2.63
6.88
1.7
1.5
—
—
—
0
0
675
5605
1.29
6.79
3.2
3.3
0.00
0.05
1.49
11
172
853
7292
1.27
6.79
2.4
2.3
139.79
218.84
u/l
4.78
805
6889
335
2512
1.39
6.78
4.0
3.4
1.48
1.93
mmol/l
1.39
287
2177
343
2583
1.38
6.77
4.0
3.4
5.71
5.83
kpa
1.47
329
2518
47
204
2.33
6.76
1.3
1.6
—
1965.71
—
0
7
1010
8833
1.25
6.55
4.6
4.3
42.44
120.96
ng/l
0.99
848
6905
232
1642
1.46
6.48
4.1
3.8
5.00
5.16
kpa
2.09
213
1579
69
355
1.97
6.48
1.4
1.4
1975.54
4107.40
e6/l
0.41
48
248
35
135
2.62
6.46
4.9
1.8
—
—
—
0
0
201
1390
1.49
6.31
3.9
3.6
1.56
1.97
mmol/l
0.69
139
1037
74
394
1.91
6.30
1.3
1.5
32.59
32.09
g/l
0.14
62
357
62
312
2.01
6.20
1.4
1.4
146231.75
89353.32
e6/l
0.33
36
176
311
2350
1.37
5.99
1.9
2.2
0.20
0.20
g/l
0.28
287
2190
36
147
2.47
5.95
1.7
1.5
—
—
—
0
0
38
161
2.38
5.81
1.7
1.4
—
—
—
0
0
505
4114
1.29
5.77
3.4
3.2
1.28
1.20
e6/l
0.12
252
2264
15
27
5.58
5.68
14.9
3.5
—
—
—
0
0
169
1156
1.50
5.62
5.1
5.2
1.77
1.56
%
2.11
161
1097
302
2295
1.36
5.61
8.0
7.2
1.27
1.37
mmol/l
0.84
297
2259
205
1459
1.44
5.57
9.4
10.0
15.22
15.82
%
2.26
199
1409
167
1142
1.50
5.56
2.9
3.3
4.24
4.39
pmol/l
1.40
139
1004
702
8140
0.80
5.46
3.8
4.2
12.52
8.37
mg/mmol
1.47
462
5060
19
57
3.35
5.44
2.2
1.6
285.82
674.28
nmol/24h
0.35
19
57
698
8090
0.80
5.38
3.2
3.5
7.00
7.13
mmol/l
0.27
594
6741
376
2985
1.31
5.18
8.4
7.6
4.87
5.10
kpa
5.51
361
2872
376
2985
1.31
5.18
8.3
7.6
12.09
11.96
kpa
0.16
361
2872
105
661
1.62
5.06
2.0
1.3
—
—
—
0
0
154
1059
1.49
5.01
5.4
5.5
0.89
0.87
%
0.19
146
1005
278
2134
1.34
4.84
2.4
2.5
33.24
40.18
u/l
1.60
240
1781
8
7
11.46
4.78
2.9
1.1
—
—
—
0
0
13
25
5.22
4.76
1.7
1.5
—
—
—
0
0
54
286
1.91
4.75
2.5
1.4
—
—
—
0
0
91
563
1.64
4.72
1.7
1.6
—
—
—
0
0
54
287
1.90
4.70
2.5
1.4
—
—
—
0
0
13
26
5.02
4.63
1.0
1.9
—
—
—
0
0
54
289
1.89
4.61
2.5
1.4
—
—
—
0
0
727
6317
1.22
4.57
4.6
4.4
0.00
0.00
estimate
1.15
324
2164
1324
12183
1.20
4.53
4.1
3.4
60.84
55.51
u/l
1.09
1272
11230
8
8
10.03
4.52
1.1
1.0
—
—
—
0
0
81
495
1.66
4.43
1.5
1.3
—
—
—
0
0
81
495
1.66
4.43
1.5
1.3
—
—
—
0
0
576
4900
1.23
4.42
3.8
3.1
2.44
2.46
mmol/l
3.74
533
4399
312
2475
1.30
4.31
9.3
8.3
113.72
120.42
g/l
6.09
307
2422
101
657
1.56
4.29
1.8
1.8
—
—
—
0
0
365
2969
1.27
4.14
8.4
7.5
0.52
1.02
mmol/l
1.30
295
2450
130
903
1.47
4.08
1.9
1.8
38.80
39.15
u/l
0.06
111
782
331
2667
1.28
4.05
8.8
7.8
95.51
95.40
%
0.11
320
2583
645
5596
1.21
4.03
4.0
3.8
0.01
0.17
estimate
0.64
300
1858
118
806
1.49
4.03
1.4
1.8
6.51
7.29
iu/ml
0.12
20
195
171
1257
1.39
3.94
1.5
1.5
—
—
—
0
0
1934
18571
1.25
3.88
39.9
18.9
73.59
74.44
ml/min/173m2
1.19
1858
17425
1871
17903
1.24
3.87
5.7
4.6
1.31
1.29
mmol/l
0.58
1776
16112
87
566
1.56
3.74
1.2
1.3
4.31
6.36
u/ml
—
7
89
87
566
1.56
3.74
1.2
1.2
1.55
3.87
u/ml
—
6
55
52
296
1.77
3.72
1.2
1.2
171.38
212.55
miu/ml
0.29
16
103
152
1108
1.40
3.69
2.5
2.2
0.00
0.78
estimate
0.50
31
320
76
483
1.59
3.62
1.2
1.2
1.32
5.26
u/ml
—
6
31
1590
15014
1.19
3.61
4.8
4.4
15.21
15.04
pmol/l
1.86
1470
13534
52
299
1.76
3.60
1.1
1.1
—
4.20
—
0
10
49
278
1.78
3.56
2.6
1.4
—
—
—
0
0
49
278
1.78
3.56
2.6
1.4
—
—
—
0
0
47
264
1.80
3.53
1.5
1.4
—
—
—
0
0
269
2152
1.28
3.49
3.4
2.9
4.25
4.49
kpa
1.36
259
2094
49
280
1.77
3.48
2.6
1.4
—
—
—
0
0
265
2134
1.27
3.27
3.4
3.1
199.13
219.57
ng/l
0.42
249
1960
48
280
1.73
3.20
1.3
1.4
6.41
6.40
mmol/l
0.01
43
267
20
86
2.34
3.08
34.8
28.8
135.40
117.90
ug/l
0.68
20
71
20
86
2.34
3.08
1.2
1.1
—
—
—
0
0
32
167
1.93
3.04
1.1
1.1
—
—
—
0
0
60
377
1.61
3.04
1.6
1.5
333.68
313.12
pmol/l
0.07
60
369
12
36
3.35
3.01
1.6
1.1
—
—
—
0
0
27
134
2.03
2.96
3.7
3.7
—
—
—
0
0
118
864
1.39
2.86
4.4
3.9
24.38
24.86
mmol/l
0.87
103
793
1043
9629
1.15
2.86
2.6
2.5
78.22
79.26
nmol/l
0.59
941
8507
87
603
1.46
2.85
2.5
2.2
122.88
127.76
g/l
0.88
74
476
67
440
1.54
2.84
1.3
1.3
—
—
—
0
0
7
14
5.01
2.73
1.0
1.3
—
—
—
0
0
2052
19982
1.24
2.71
41.7
23.2
139.43
139.65
mmol/l
3.25
2035
19593
6
10
6.01
2.70
2.7
4.9
—
—
—
0
0
61
401
1.54
2.60
1.6
1.9
4.34
4.69
mmol/24h
0.35
54
342
11
36
3.07
2.56
1.2
1.1
—
—
—
0
0
44
269
1.65
2.54
1.1
1.3
270.42
275.96
mosm/kgh2o
0.98
33
194
45
277
1.64
2.53
4.0
4.0
—
—
—
0
0
86
1190
0.71
2.49
2.2
2.1
3.77
3.46
ratio
1.17
68
977
2052
20010
1.23
2.49
45.3
23.4
4.03
4.00
mmol/l
6.99
2034
19593
28
152
1.85
2.42
1.2
1.1
—
—
—
0
0
11
38
2.90
2.41
1.7
1.5
—
—
—
0
0
18
84
2.15
2.34
1.6
1.2
—
—
—
0
0
73
513
1.44
2.29
6.9
7.6
105.03
105.19
mmol/l
0.12
65
466
8
23
3.49
2.27
1.1
1.1
—
—
—
0
0
8
23
3.49
2.27
1.5
1.1
—
—
—
0
0
289
2450
1.21
2.26
4.4
3.8
—
—
—
0
0
21
106
1.99
2.25
2.6
1.5
10.61
10.41
ug/l
0.02
21
92
123
945
1.32
2.24
2.1
3.4
53.57
4505.85
u/ml
0.91
105
819
75
533
1.42
2.22
1.3
1.2
—
—
—
0
0
28
157
1.79
2.21
1.2
1.1
—
—
—
0
0
28
157
1.79
2.21
1.2
1.1
—
—
—
0
0
20
101
1.99
2.15
1.3
2.0
1068.77
842.24
e6/l
0.25
13
74
73
520
1.42
2.14
1.3
1.6
—
—
—
0
0
29
167
1.75
2.11
1.2
1.1
—
—
—
0
0
229
1914
1.22
2.09
3.2
3.8
86.09
93.38
ng/l
0.74
206
1632
75
540
1.40
2.08
1.3
1.2
—
—
—
0
0
17
83
2.06
2.01
1.2
1.3
129.00
171.31
mmol/24h
1.86
17
83
1444
15059
0.89
1.96
60.0
25.0
326.61
331.41
g/l
30.16
1438
14964
11
243
0.45
1.96
1.4
1.2
1.30
1.48
nmol/l
0.21
11
216
18
91
1.99
1.95
1.3
1.9
4114.00
23280.78
e6/l
0.46
11
51
189
1565
1.23
1.91
7.2
6.9
23.90
24.47
mmol/l
1.56
181
1500
12
52
2.31
1.87
2.8
1.8
1.19
1.12
ug/l
0.06
12
47
2046
20033
1.18
1.86
35.9
13.3
23.87
25.33
u/l
5.41
2024
19376
21
115
1.83
1.83
4.3
1.7
41.30
39.38
g/l
0.92
21
115
5
12
4.17
1.82
1.2
1.0
—
—
—
0
0
871
8121
1.12
1.81
4.5
4.3
0.01
0.11
estimate
1.16
301
1954
1844
17928
1.14
1.80
6.1
5.6
2.13
2.01
mu/l
2.41
1755
16303
61
836
0.72
1.75
1.8
1.9
3.22
3.42
mmol/l
0.62
42
623
258
2226
1.18
1.70
2.3
2.2
224.03
149.07
ug/g
1.20
194
1774
30
187
1.61
1.69
1.2
1.2
—
—
—
0
0
25
149
1.69
1.67
1.2
1.2
—
—
—
0
0
20
112
1.79
1.64
1.2
1.4
—
—
—
0
0
304
2666
1.16
1.64
2.9
4.2
19.45
22.21
ug/l
0.11
245
2226
5
14
3.58
1.61
1.6
1.0
21.04
20.43
%
—
5
14
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
5
14
3.58
1.61
1.2
1.0
7.36
7.24
%
—
5
14
5
14
3.58
1.61
1.6
1.0
40.80
38.56
%
—
5
14
6
20
3.00
1.58
1.5
1.1
—
—
—
0
0
7
26
2.70
1.58
1.6
1.2
—
—
—
0
0
20
114
1.76
1.56
1.3
1.6
6.10
7.65
u/l
0.43
14
99
5
15
3.34
1.52
1.8
1.0
—
—
—
0
0
81
627
1.30
1.49
3.4
3.2
1.34
1.60
mmol/l
2.93
76
611
196
1681
1.18
1.42
11.2
9.3
93.73
93.82
%
0.06
196
1672
9
40
2.25
1.40
1.8
1.2
—
—
—
0
0
87
688
1.27
1.38
1.6
1.6
33.70
22.05
u/ml
0.36
14
114
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
119
1.69
1.37
1.3
1.1
—
—
—
0
0
187
1606
1.18
1.34
3.3
2.9
121.17
127.93
g/l
3.19
174
1559
18
296
0.61
1.33
1.2
1.2
1.36
1.54
g/l
2.24
18
296
21
129
1.63
1.30
1.2
1.1
—
—
—
0
0
15
255
0.59
1.27
1.1
1.2
0.68
0.66
ratio
—
7
50
32
219
1.47
1.26
1.1
1.1
—
55.14
—
0
14
10
49
2.05
1.22
1.1
1.2
—
—
—
0
0
42
305
1.38
1.21
3.2
2.5
-0.00
0.48
mmol/l
0.37
42
295
7
31
2.26
1.10
1.4
1.1
—
—
—
0
0
246
2194
1.14
1.10
1.4
1.3
—
—
—
0
0
33
236
1.40
1.06
3.0
3.4
14.00
11.19
index
1.54
24
128
431
4660
0.91
1.06
3.2
3.5
0.76
0.79
ug/l
0.18
308
3271
7
34
2.06
1.03
1.6
1.2
—
—
—
0
0
150
1300
1.16
1.02
4.4
3.8
40.74
47.25
%
2.65
144
1278
1897
18635
1.10
1.01
6.6
5.5
1.32
1.46
mmol/l
41.18
1817
16973
88
728
1.22
1.00
1.4
1.2
—
—
—
0
0
7
35
2.00
1.00
1.6
1.2
—
—
—
0
0
7
37
1.89
0.94
1.1
1.2
—
—
—
0
0
1909
18775
1.10
0.94
6.7
5.6
4.09
4.49
mmol/l
54.45
1831
17239
6
28
2.15
0.91
1.7
1.0
—
—
—
0
0
11
63
1.75
0.90
1.4
1.1
—
—
—
0
0
43
332
1.30
0.89
1.2
1.1
—
—
—
0
0
599
6337
0.93
0.89
4.3
4.9
21.60
21.84
%
0.14
296
3348
54
432
1.26
0.86
1.3
1.1
0.78
6.44
eliau/ml
—
5
31
11
64
1.72
0.86
1.4
1.1
—
—
—
0
0
33
433
0.76
0.83
1.4
1.4
0.96
0.83
nmol/l
0.49
28
354
38
489
0.77
0.82
5.3
3.7
33.18
27.95
mg/l
0.35
26
338
68
562
1.22
0.82
1.3
1.2
—
—
—
0
0
6
32
1.88
0.81
1.5
1.0
—
—
—
0
0
163
1828
0.88
0.81
1.5
1.7
1.49
1.57
%
0.95
136
1521
134
1178
1.15
0.79
3.5
3.2
24.66
25.31
mmol/l
1.20
124
1138
2053
20294
1.10
0.79
54.1
25.5
83.42
81.96
umol/l
1.27
2042
20034
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
8
48
1.67
0.78
1.0
1.2
—
—
—
0
0
5
97
0.51
0.78
1.2
1.4
33.00
29.16
umol/l
—
5
89
248
2707
0.91
0.77
9.3
7.6
—
—
—
0
0
455
4836
0.93
0.77
4.5
4.5
1.02
1.02
kg/l
2.35
331
3262
99
1143
0.86
0.76
1.4
1.3
57.19
217.59
u/ml
9.50
82
1065
136
1203
1.14
0.75
3.5
3.7
1.02
1.02
ratio
0.55
128
1096
30
228
1.32
0.73
1.2
1.3
—
—
—
0
0
50
611
0.81
0.72
1.3
1.7
8374.61
14010.76
e6/l
1.00
33
416
35
444
0.79
0.71
1.4
1.4
—
—
—
0
0
5
26
1.93
0.70
1.0
1.1
108.80
97.23
titre
—
5
26
17
118
1.44
0.69
1.0
1.0
—
—
—
0
0
5
27
1.85
0.68
2.0
1.0
—
—
—
0
0
5
27
1.85
0.68
1.2
1.1
—
—
—
0
0
27
205
1.32
0.67
1.2
1.3
—
—
—
0
0
757
7868
0.94
0.66
5.5
6.0
4.58
3.73
ug/l
0.30
668
7046
11
71
1.55
0.62
1.5
1.1
—
—
—
0
0
71
821
0.86
0.59
1.0
1.1
—
—
—
0
0
0
22
0.00
0.59
0.0
1.2
—
8.44
—
0
22
11
72
1.53
0.59
1.0
1.0
—
—
—
0
0
40
328
1.22
0.57
1.3
1.3
16.10
9.90
u/l
1.99
32
265
5
88
0.57
0.56
1.4
1.1
—
—
—
0
0
8
55
1.46
0.56
1.0
1.3
8.26
9.29
ug/l
—
8
55
97
1090
0.89
0.55
1.2
1.2
109.86
134.33
u/ml
0.33
29
388
1908
18865
1.06
0.55
6.2
5.8
5.94
6.08
mmol/l
5.77
1783
17030
81
711
1.14
0.54
1.4
1.5
282.61
270.16
ug/g
0.25
45
435
73
638
1.15
0.53
3.2
3.4
0.80
0.81
nmol/l
0.16
56
527
9
65
1.39
0.50
1.0
2.3
21.37
142.08
ug/l
—
9
56
10
67
1.49
0.49
1.5
1.1
—
—
—
0
0
11
76
1.45
0.48
1.6
1.5
—
—
—
0
0
16
211
0.76
0.47
1.1
1.4
641543.50
82185.13
e6/l
—
10
141
23
182
1.27
0.46
1.1
1.2
116.91
100.25
pmol/l
0.49
23
182
23
182
1.27
0.46
1.0
1.1
—
—
—
0
0
437
4191
1.05
0.43
1.3
1.3
1.93
1.44
u/ml
0.17
66
1066
49
563
0.87
0.42
2.8
2.2
109.97
88.36
ug/min
0.24
27
328
10
70
1.43
0.41
1.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.6
—
22.86
—
0
7
0
17
0.00
0.40
0.0
1.4
—
52.80
—
0
17
5
34
1.47
0.40
3.6
8.5
11.40
10.25
%
—
5
34
17
132
1.29
0.40
1.5
1.9
—
—
—
0
0
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.6
—
14.45
—
0
11
8
61
1.31
0.39
1.4
1.1
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
4032.33
—
0
12
77
694
1.11
0.38
1.6
1.6
0.35
0.35
mg/l
0.01
37
308
473
4901
0.96
0.38
1.6
1.8
27937865.32
22740160.81
pmol/l
0.07
383
4015
9
68
1.32
0.37
1.1
1.1
—
—
—
0
0
16
202
0.79
0.36
1.1
1.1
0.15
1.39
u/ml
—
7
108
14
108
1.30
0.35
6.1
6.6
3.47
185.10
ug/l
—
6
69
9
126
0.71
0.35
1.3
1.6
104.44
88.83
umol/l
—
9
126
6
46
1.31
0.33
1.2
1.1
—
—
—
0
0
74
674
1.10
0.32
4.1
4.0
3.90
3.91
mmol/l
0.07
74
667
10
74
1.35
0.32
1.1
1.2
142.94
252.77
iu/ml
—
10
74
16
129
1.24
0.30
2.2
2.4
—
—
—
0
0
366
3533
1.04
0.30
1.3
1.3
37.41
37.38
iu/ml
0.00
114
1113
19
157
1.21
0.29
2.4
2.2
7.11
8.32
mmol/l
1.21
19
157
7
56
1.25
0.29
1.6
2.9
5.29
507.80
ug/l
—
7
56
2053
20419
1.05
0.29
67.7
28.7
97.34
91.76
fl
93.24
2044
20150
2053
20421
1.05
0.28
68.6
29.3
39.12
39.79
%
7.02
2044
20144
2053
20421
1.05
0.28
67.8
28.8
4.15
4.41
e12/l
41.41
2025
19867
44
491
0.89
0.28
1.3
1.9
3.20
16.60
iu/l
0.55
17
186
2053
20423
1.05
0.27
67.9
28.8
9.47
6.84
e9/l
28.17
2024
19874
2053
20424
1.05
0.27
68.3
29.0
127.53
133.15
g/l
44.92
2044
20164
10
77
1.30
0.26
5.7
2.5
4.78
4.86
kpa
—
10
77
10
77
1.30
0.26
5.7
2.5
11.24
10.07
kpa
—
10
77
5
74
0.68
0.26
1.6
1.3
—
—
—
0
0
2052
20419
1.04
0.25
68.1
28.8
371.76
242.67
e9/l
188.27
2030
19955
51
465
1.10
0.24
1.2
1.3
16.11
46.28
e6/l
0.81
37
338
1928
19171
1.03
0.23
7.6
6.5
2.29
2.57
mmol/l
41.73
1849
17518
23
264
0.87
0.23
1.4
1.5
—
—
—
0
0
152
1592
0.95
0.22
2.5
2.3
12.14
13.08
nmol/l
0.63
127
1414
14
116
1.21
0.22
1.1
1.1
—
—
—
0
0
37
334
1.11
0.21
1.4
1.3
38.96
31.35
iu/l
0.79
32
283
0
11
0.00
0.21
0.0
1.3
—
2.64
—
0
11
0
10
0.00
0.21
0.0
1.0
—
0.07
—
0
5
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
51
469
1.09
0.21
1.2
1.4
1579.82
724.26
e6/l
0.34
38
362
5
43
1.16
0.21
3.6
8.3
4.98
5.23
kpa
—
5
43
30
335
0.89
0.21
1.3
1.5
—
—
—
0
0
207
1998
1.04
0.19
2.5
2.5
0.36
0.49
e6/l
0.63
200
1910
1847
18561
0.98
0.17
7.0
7.3
37.27
40.28
mmol/mol
54.13
1773
17113
28
310
0.90
0.17
2.0
2.3
29.11
20.89
mg/l
—
9
107
164
1697
0.96
0.16
1.4
1.5
—
—
—
0
0
9
79
1.14
0.15
1.0
1.1
1475.78
1507.35
miu/ml
—
9
79
21
188
1.12
0.14
1.8
2.1
3.15
1.40
u/field
0.74
13
99
7
86
0.81
0.14
1.0
1.1
—
—
—
0
0
225
2193
1.03
0.14
1.5
1.4
—
—
—
0
0
11
95
1.16
0.11
1.5
1.4
208.42
161.51
pmol/l
0.32
11
95
12
105
1.14
0.11
1.1
1.2
—
—
—
0
0
273
2778
0.98
0.10
5.5
5.4
31.72
33.26
%
1.76
206
1751
20
183
1.09
0.10
2.1
2.2
582.40
621.87
ml
—
10
117
212
2163
0.98
0.10
2.3
2.5
4.71
7.50
ug/l
3.13
175
1910
843
8368
1.01
0.09
2.0
2.0
1.42
1.32
mmol/l
1.68
740
6867
6
56
1.07
0.08
2.8
2.4
160.00
130.92
nmol/l
—
6
48
17
157
1.08
0.07
4.9
5.3
93.80
25.44
u/ml
—
5
43
11
122
0.90
0.07
1.4
1.4
0.27
0.22
nmol/l
—
6
85
9
87
1.03
0.07
1.2
1.3
—
—
—
0
0
14
128
1.09
0.06
1.4
1.4
1.40
1.07
nmol/l
—
8
92
17
158
1.08
0.06
1.4
1.8
116.97
113.91
ng/l
0.04
17
158
72
702
1.03
0.05
1.5
1.7
—
—
—
0
0
10
90
1.11
0.05
2.0
1.5
101.60
83.35
umol/l
—
5
57
337
3341
1.01
0.05
1.3
1.3
11.07
12.98
u/ml
0.21
104
1172
55
535
1.03
0.05
1.6
2.7
31.46
36.82
umol/l
0.76
46
475
58
566
1.03
0.04
2.0
3.5
731.34
824.71
u/ml
0.05
48
525
20
190
1.05
0.04
1.3
1.1
2.84
2.09
eliau/ml
—
7
59
14
131
1.07
0.03
1.1
1.2
9.48
10.14
mmol/l
0.27
14
123
12
112
1.07
0.03
1.6
1.3
29.48
18.93
umol/l
0.48
12
100
13
122
1.07
0.02
1.6
1.1
—
—
—
0
0
63
639
0.99
0.01
1.6
1.6
—
—
—
0
0
65
641
1.01
0.01
1.2
1.4
—
—
—
0
0
13
123
1.06
0.01
1.6
1.1
—
—
—
0
0
120
1210
0.99
0.01
1.3
1.3
73.50
57.29
au/ml
—
8
86
10
94
1.06
0.01
1.1
1.2
—
—
—
0
0
11
104
1.06
0.01
1.8
1.2
270.82
368.22
u/l
0.26
11
97
16
166
0.96
0.00
2.0
3.0
17.20
29.12
mg/l
—
10
125
26
255
1.02
0.00
2.6
1.7
—
—
—
0
0
26
259
1.00
0.00
1.3
1.6
64.60
63.71
%
0.04
15
160
15
146
1.03
0.00
1.5
1.3
0.57
2.26
u/ml
—
6
85
134
1337
1.00
0.00
2.6
2.5
18.20
20.78
au/ml
0.09
14
92
21
213
0.99
0.00
3.0
1.7
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
7.74
—
0
8
0
5
0.00
0.00
0.0
1.2
—
1.70
—
0
5
0
5
0.00
0.00
0.0
1.0
—
0.01
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
8
82
0.98
-0.00
1.5
2.5
0.65
0.61
mmol/l
—
8
82
5
52
0.96
-0.00
1.0
1.3
7.20
10.65
mm/h
—
5
52
5
49
1.02
-0.00
1.2
1.1
—
—
—
0
0
6
68
0.88
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
7.2
—
67.00
—
0
6
5
49
1.02
-0.00
2.8
2.7
14.78
14.70
ml/dl
—
5
44
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
52
0.96
-0.00
1.2
1.3
102.40
107.52
%
—
5
46
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).